Back to top

Top Ranked Income Stocks to Buy for February 13th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, February 13th:

Avianca Holdings S.A. (AVH - Free Report) : This passenger and cargo air transportation services provider has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 4.89%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.1%.

Canadian Imperial Bank of Commerce (CM - Free Report) : This diversified financial institution has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 4.83%, compared with the industry average of 3.17%. Its five-year average dividend yield is 4.53%.

Edison International (EIX - Free Report) : This company that engages in the generation, transmission, and distribution of electricitywitnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 4.08%, compared with the industry average of 2.94%. Its five-year average dividend yield is 2.94%.

Edison International Dividend Yield (TTM)

Edison International Dividend Yield (TTM)

Edison International dividend-yield-ttm | Edison International Quote

Consolidated Edison, Inc. (ED - Free Report) : This company that engages in regulated electric, gas, and steam delivery businesses has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 3.77%, compared with the industry average of 2.94%. Its five-year average dividend yield is 3.82%.

See the full list of top ranked stocks here

Find more top income stocks with some of our great premium screens.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>